
SaNOtize
An innovative biotech company, using a patented platform technology for topical delivery of NO, to treat upper respiratory and dermal infections.
Employees
Enterprise value
$96—144m
Authorizing premium user...
An innovative biotech company, using a patented platform technology for topical delivery of NO, to treat upper respiratory and dermal infections.